NO802015L - Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater. - Google Patents

Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.

Info

Publication number
NO802015L
NO802015L NO802015A NO802015A NO802015L NO 802015 L NO802015 L NO 802015L NO 802015 A NO802015 A NO 802015A NO 802015 A NO802015 A NO 802015A NO 802015 L NO802015 L NO 802015L
Authority
NO
Norway
Prior art keywords
procedure
preparation
physiologically active
indolizin
derivatives
Prior art date
Application number
NO802015A
Other languages
English (en)
Other versions
NO153496C (no
NO153496B (no
Inventor
Gilbert Rosseels
Pierre Nokin
Original Assignee
Labaz Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Nv filed Critical Labaz Nv
Publication of NO802015L publication Critical patent/NO802015L/no
Publication of NO153496B publication Critical patent/NO153496B/no
Publication of NO153496C publication Critical patent/NO153496C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO802015A 1979-07-06 1980-07-04 Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater. NO153496C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7923599 1979-07-06

Publications (3)

Publication Number Publication Date
NO802015L true NO802015L (no) 1981-01-07
NO153496B NO153496B (no) 1985-12-23
NO153496C NO153496C (no) 1986-05-14

Family

ID=10506339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802015A NO153496C (no) 1979-07-06 1980-07-04 Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.

Country Status (24)

Country Link
US (1) US4400387A (no)
EP (1) EP0022762B1 (no)
JP (1) JPS5618979A (no)
AR (1) AR225314A1 (no)
AT (1) AT375078B (no)
AU (1) AU529725B2 (no)
CA (1) CA1153379A (no)
DD (1) DD151940A5 (no)
DE (1) DE3060097D1 (no)
DK (1) DK146962C (no)
ES (1) ES493139A0 (no)
FI (1) FI67217C (no)
GR (1) GR69280B (no)
HU (1) HU182151B (no)
IE (1) IE49994B1 (no)
IN (1) IN151594B (no)
NO (1) NO153496C (no)
NZ (1) NZ193926A (no)
OA (1) OA06563A (no)
PL (1) PL125597B1 (no)
PT (1) PT71424A (no)
SU (1) SU993817A3 (no)
YU (1) YU171880A (no)
ZA (1) ZA803434B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103702A (en) * 1999-05-24 2000-08-15 Board Of Trustees Of The University Of Illinois Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
WO2001007054A1 (en) * 1999-07-22 2001-02-01 Supergen, Inc. Methods for treating autoimmune diseases
FR2805460A1 (fr) * 2000-02-25 2001-08-31 Oreal Compositions de teinture des fibres keratiniques contenant des derives d'indolizine cationiques et procede de teinture
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
FR2859997B1 (fr) * 2003-09-18 2006-02-03 Sanofi Synthelabo Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
FR2896247B1 (fr) 2006-01-13 2008-02-29 Sanofi Aventis Sa Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
CA2755132C (en) 2009-03-31 2018-02-13 Kissei Pharmaceutical Co., Ltd. Indolizine derivative and use thereof for medical purposes
US20100261666A1 (en) * 2009-04-14 2010-10-14 The Board Of Trustees Of The University Of Illinois Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis
CN103221412B (zh) * 2010-09-29 2015-08-19 橘生药品工业株式会社 (氮杂)中氮茚衍生物及其药物用途
CA2998034C (en) * 2015-09-10 2021-05-04 Dongfang Shi A group of compounds used for the treatment or prevention of hyperuricemia or gout
CN108084186B (zh) 2016-11-16 2021-06-25 江苏新元素医药科技有限公司 Urat1抑制剂及其应用
WO2018090921A1 (zh) 2016-11-16 2018-05-24 江苏新元素医药科技有限公司 Urat1抑制剂及其应用
JP6915907B2 (ja) * 2017-05-26 2021-08-04 江▲蘇▼新元素医▲薬▼科技有限公司Ｊｉａｎｇｓｕ Ａｔｏｍ Ｂｉｏｓｃｉｅｎｃｅ Ａｎｄ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． 尿酸排泄を促進するｕｒａｔ１阻害剤
CN114213331B (zh) * 2017-05-26 2024-06-21 江苏新元素医药科技有限公司 一类urat1抑制剂及其应用
CN112979661B (zh) * 2018-01-19 2022-05-17 苏州信诺维医药科技股份有限公司 杂环化合物、制备方法及其在医药上的应用
CN110283167A (zh) * 2018-11-14 2019-09-27 贵州省中国科学院天然产物化学重点实验室 一种抗心率失常药物布托普洛嗪的制备方法
WO2022169974A1 (en) 2021-02-05 2022-08-11 Nexys Therapeutics, Inc. Inhibitors of urat1 and pharmaceutical uses thereof
WO2023221078A1 (en) * 2022-05-20 2023-11-23 Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. Solid forms of a compound for treating or preventing hyperuricemia or gout
WO2025237171A1 (zh) * 2024-05-11 2025-11-20 广州市联瑞制药有限公司 嘧啶并五元氮杂环酚类化合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU430639A1 (ru) 1972-06-05 1978-02-28 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.М.В.Ломоносова Способ получени 1-пиридилиндолизинов
GB1518443A (en) * 1976-02-19 1978-07-19 Labaz Indolizine derivatives and process for preparing the same
FI61030C (fi) 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat

Also Published As

Publication number Publication date
DK146962C (da) 1984-08-06
PL225479A1 (no) 1981-10-30
ES8105710A1 (es) 1981-06-16
DK146962B (da) 1984-02-27
IE801349L (en) 1981-01-06
AR225314A1 (es) 1982-03-15
GR69280B (no) 1982-05-13
AU5948780A (en) 1981-01-15
US4400387A (en) 1983-08-23
EP0022762B1 (fr) 1981-11-25
IE49994B1 (en) 1986-01-22
EP0022762A1 (fr) 1981-01-21
NO153496C (no) 1986-05-14
FI67217C (fi) 1985-02-11
ZA803434B (en) 1981-05-27
FI802165A7 (fi) 1981-01-07
CA1153379A (en) 1983-09-06
PT71424A (en) 1980-07-01
IN151594B (no) 1983-06-04
JPS5618979A (en) 1981-02-23
ES493139A0 (es) 1981-06-16
SU993817A3 (ru) 1983-01-30
ATA354380A (de) 1983-11-15
DK291180A (da) 1981-01-07
OA06563A (fr) 1981-07-31
NZ193926A (en) 1984-05-31
AU529725B2 (en) 1983-06-16
PL125597B1 (en) 1983-05-31
DD151940A5 (de) 1981-11-11
HU182151B (en) 1983-12-28
DE3060097D1 (en) 1982-01-28
NO153496B (no) 1985-12-23
FI67217B (fi) 1984-10-31
YU171880A (en) 1983-10-31
AT375078B (de) 1984-06-25

Similar Documents

Publication Publication Date Title
NO145657C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO784211L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
NO784231L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive benzotiazinderivater
NO152899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO782127L (no) Fremgangsmaate for fremstilling av fysiologisk aktive isoksazolo-pyridin-derivater
NO159019C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater.
NO802015L (no) Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO821085L (no) Fremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
NO154055C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater.
NO803115L (no) Fremgangsmaate for fremstilling av stivelselim
NO152839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO146776C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridobenzodiazepiner
NO154131C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.